Association of OAS1 and MxA variants with COVID-19 in Pakistani patients
View abstract on PubMed
Summary
This summary is machine-generated.The OAS1 rs2660 AG genotype significantly reduced the risk of COVID-19 susceptibility in Pakistani individuals. This genetic variant offers insights into host factors influencing viral infection outcomes.
Area Of Science
- Genetics
- Virology
- Immunology
Background
- Coronaviruses, including SARS-CoV-2, cause significant global health issues like COVID-19.
- Host genetic factors, such as OAS1 and MxA gene variants, may influence susceptibility and disease severity.
- Understanding these genetic determinants is crucial for managing COVID-19's diverse clinical spectrum.
Purpose Of The Study
- To investigate the association between OAS1 rs2660 and MxA rs2071430 genotypes and COVID-19 susceptibility and severity.
- To analyze the impact of specific genotypes on disease risk within a Pakistani population.
Main Methods
- A comparative cross-sectional study design was employed.
- Fifty COVID-19 patients and fifty healthy controls were recruited.
- Genotyping was performed for OAS1 rs2660 and MxA rs2071430 variants.
Main Results
- The OAS1 rs2660 AG genotype was associated with a decreased risk of COVID-19 susceptibility across multiple genetic models (codominant, dominant, overdominant).
- No significant association was found between OAS1 rs2660 genotypes and COVID-19 severity.
- The MxA rs2071430 variant showed no significant association with COVID-19 susceptibility.
Conclusions
- The OAS1 rs2660 AG genotype confers a protective effect against COVID-19 susceptibility in the Pakistani population.
- This study highlights the role of OAS1 gene variants in determining individual susceptibility to COVID-19.
- Findings can inform future research on genetic risk stratification and personalized treatment strategies for COVID-19.
Related Concept Videos
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

